跳转至内容
Merck

SML2320

Sigma-Aldrich

Ornipressin acetate salt

≥98% (HPLC)

别名:

8-L-Ornithinevasopressin acetate, Cys-Tyr-Phe-Gln-Asn-Cyes-Pro-Orn-Gly-NH2 [Disulfide Bridge: 1-6] acetate, Onithine-vasopressin acetate, Orn8-vasopressin acetate

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C45H63N13O12S2 · xC2H4O2
分子量:
1042.19 (free base basis)
分類程式碼代碼:
12352200
NACRES:
NA.77

化驗

≥98% (HPLC)

形狀

powder

顏色

white to off-white

運輸包裝

wet ice

儲存溫度

−20°C

SMILES 字串

S1SC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C1)C(=O)N4[C@@H](CCC4)C(=O)N[C@@H](CCCN)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N)Cc3ccccc3)Cc2ccc(cc2)O)N.OC(=O)C

InChI 密鑰

AYJSELDHDXYDKX-HPILINOVSA-N

生化/生理作用

Ornipressin is a potent vasoconstrictor agent used in surgery for hemostasis and in regional anesthesia for prolongation of nerve block. Ornipressin is a vasopressin agonist specific for the V1 receptor with low antidiuretic activity.
vasopressin agonist specific for the V1 receptor with low antidiuretic activity

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Claudia Tüller et al.
Respiration; international review of thoracic diseases, 71(4), 397-401 (2004-08-19)
Ornipressin and terlipressin, two ADH-derivates, are instilled endobronchially for bronchoscopy- related bleeding without sufficient evidence of efficacy, nor safety. To compare the immediate hemodynamic effects of ornipressin and terlipressin used for procedure-related bleeding during flexible bronchoscopy. This retrospective study included
M Guevara et al.
Hepatology (Baltimore, Md.), 27(1), 35-41 (1998-01-13)
Hepatorenal syndrome is caused by a marked vasoconstriction of the renal circulation. It is suggested that the renal vasoconstriction is related to an overactivity of vasoconstrictor systems secondary to a vasodilation of the arterial circulation that causes a reduction in
Sammy Ngichabe et al.
Annals of surgical innovation and research, 9, 10-10 (2015-11-17)
Myomectomy is a surgical technique used for removal of uterine fibroids and historically hysterectomy has represented the mainstay of treatment. The options of conservative surgical approaches mainly aim at retention of fertility but have to be balanced against potential risks

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门